Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Virtual Event
2020 mPower Virtual Conference
On-Demand
Over the past several months, the Mitchell | Genex teams have been closely monitoring the developments surrounding COVID-19 and the CDC’s recommend
Workers' Comp
Article
Six Ways TCMs Are Crucial During COVID-19
Telephonic Case Management: Always Putting the Injured Worker First Our telephonic case manager (TCM) team is constantly communicat
Auto Physical Damage
News Release
Video: CIECAcast Experts Discuss Industry Challenges Amidst Coronavirus
Mitchell
News Release
Claims Journal: Interview with Michele Hibbert-Iacobacci on COVID-19
Mitchell Senior Vice President of Regulatory Compliance Management Michele Hibbert-Iacobacci shared her thoughts and expertise with Claims Journal
Workers' Comp
Article
Field Case Management in the Face of COVID-19
As Americans practice social distancing to prevent further spread of COVID-19, it is important injured
Workers' Comp
Article
Field Case Management in the Face of COVID-19
As Americans practice social distancing to prevent further spread of COVID-19, it is important injured employees safely continue to receive the ser